Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents.
about
Mitochondrial DNA polymerase editing mutation, PolgD257A, reduces the diabetic phenotype of Akita male mice by suppressing appetite.Obesity treatment: novel peripheral targets.Clinical implications of amylin and amylin deficiency.Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus.Amylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding.Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cellsPlasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats.Pancreatic signals controlling food intake; insulin, glucagon and amylinExpression, purification, and biological activity of the recombinant pramlintide precursor.In vitro study of partially hydrolyzed poly(2-ethyl-2-oxazolines) as materials for biomedical applications.Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP.Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes.Degradation of islet amyloid polypeptide by neprilysin.Antipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression.Novel therapies for the management of type 2 diabetes mellitus: part 1. pramlintide and bromocriptine-QR.Amylin-mediated control of glycemia, energy balance, and cognition.Islet amyloid polypeptide acts on glucose- stimulated beta cells to reduce voltage-gated calcium channel activation, intracellular Ca(2+) concentration, and insulin secretion.Ghrelin, Amylin, Gastric Inhibitory Peptide and Cognition in Middle-Aged HIV-Infected and Uninfected Women: The Women's Interagency HIV Study.Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1/CIP1.The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours.Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior.Amylin-induced cytotoxicity is associated with activation of caspase-3 and MAP kinases.Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes.Fe-oxy adducts of heme-Aβ and heme-hIAPP complexes: intermediates in ROS generation.The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes.Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses.Circadian anorectic effects of peripherally administered amylin in rats.Co-expression of the calcitonin receptor gene in the hypothalamic kisspeptin neurons in female rats.
P2860
Q30431983-8219EAE3-7583-4195-A4CA-4BC60974B5ACQ33607971-26E6B6D3-F2B2-457C-B688-9C9E41E284F3Q33757375-E04763ED-7DD3-4757-A2F1-120C34940D42Q34121094-49676B3C-B62F-457B-9299-D3322256A2E5Q34481692-5B40EF1E-4B12-413F-9A10-69228BA84F18Q34499302-C5D378D5-7387-4338-B9CF-E00207AAF7C2Q34982786-73E5A840-E36B-4A0A-9EDA-3CE56DE960F8Q35049663-7B57881A-29D9-4103-A669-795837022A62Q35140241-76522EE1-C395-4098-8DF4-4994E2D47283Q35147028-E0D745CB-61B2-4E50-9DDA-23386E0482BCQ35580002-21689628-96E1-481F-ADDE-B9F61226F2B5Q36402230-9E47D990-AD14-4693-9324-0785CEBF78D7Q36518439-1176D643-1A59-4D29-826B-CB6CF0A0D522Q36816194-9B639207-6049-4D3F-91AF-5F33E6A60910Q36862586-307A3082-4EF5-4E93-B4EF-164F9151AAB8Q37650208-0C7A7052-FCA5-4B0C-9F95-71F8765AA3C0Q38085727-C163FEED-1735-4FE8-9BB4-03BC9434C3C1Q38753342-BD7A5E7C-26BC-47D0-A68A-8FE4706EB765Q39965850-F036BECF-6B37-4DB0-89E3-008D522B39A7Q40129940-E707E38D-C7D3-4165-ACBE-A7DA9C9E2496Q40162927-167381E2-33E0-4B5E-AD87-07005544ADA6Q40937222-B6B833E3-8E3F-4EA4-96E7-7D8507424EF5Q41113173-20EE4123-4180-47C9-BE98-2DFD8F571B7FQ42270982-BA34CA3C-F440-489A-8A06-46984634ED6AQ42927518-5E392DDD-0426-48E1-996B-CFE1AD5C5E2EQ43738034-6C5D3C4A-9E1A-4908-87A5-4DCB6AA05DE4Q44279951-29D68071-9555-4C22-AB7F-55DF1AD6E5E7Q46140543-8258B56E-EB8D-439F-A715-D45A5E16C263Q46460032-66E3B128-2724-4C10-9ADC-10953C1FDC37Q46934886-DD88CCBE-55AC-41C5-A3B4-B1A57BE34326Q47706748-71AE5D5A-3D18-42D6-94E1-C0ECDC1C4230Q48797727-B122A779-817F-4AC4-A781-FC0BA4CB3571Q55244935-2830E252-61DF-4782-8540-873529DE8799
P2860
Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents.
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@ast
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@en
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@nl
type
label
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@ast
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@en
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@nl
prefLabel
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@ast
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@en
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@nl
P1476
Co-secretion of amylin and ins ...... mones and hypoglycemic agents.
@en
P2093
P356
10.1016/0006-291X(91)91325-7
P407
P577
1991-08-01T00:00:00Z